Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...
In 2016, the Singapore government committed to a S$4 billion budget to drive research and commercialisation activities i...
Japanese headquartered Chugai Pharmaceutical has already developed world-class technologies for antibody engineeri...
Digital transformation in healthcare has been at breakneck speed since the outbreak of the COVID-19 pandemic. It took ju...
MiyaHealth, a Singapore based health technology company is transforming this space, to create a much needed data reposit...
With the innovation boom in Asia and many early-stage assets emerging, the time is ripe for Asian economies to establish...
What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes t...
Global challenges are too large to tackle in isolation. The creation of new shared value in public research through acad...
From popular over-the-counter medications like paracetamol to more complicated drugs and vaccines, pharmacovigilance pla...
The healthcare industry is becoming increasingly information-driven. Smart machines are creating a positive impact to en...
The permanent shift in consumer preferences, rising expectations for enhanced customer experiences (CX) and digital tran...
It's estimated that one in three people in developing countries can't get essential medicines on a regular basis. Even i...
Can automation and AI leverage an effective Pharmacovigilance by tackling the consequences of adverse events (AEs)? Wh...
How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and busi...
